AHZ (ASX) News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval

Originally posted by iceman.11: ↑

Dv, I do not not make ‘sport’ out of ‘baiting’ posters, (my posting history should show that) but you are your own ‘worst’ enemy!

I have tried to engage with you in meaningful dialogue in the past, one claim you made was ‘I don’t have the time’ to engage with you!.

Everything you say on the ADO site is in direct contrast to what you say on the AHZ site, it stood out straight away, your claims ‘I was stalking you’ by commenting on that, utterly baseless, I had been invested in that stock and followed it FOR YEARS, (bought at 11 cents and sold at 9 cents), your claim to balance Admedus ‘pessimism’ is ‘belied’ by the fact that when the hype at Admedus was at its absolute height you were no where to be seen to counter that with the realities that existed, I did.

My claim that ‘I AM NOT A TRADER’ seems to challenge you, that I have ‘ulterior motives’ seems to appeal to you, if you have followed my posts over the years you would know that belies your claim.

Have gone against the flow for ‘years’ and copped it!

That you are being ‘targeted’ does not stop you from targeting ‘naysayers’ on AHZ, fact!

You say you are not a ‘aplogist’, what do you call the following insights from you; ‘It’s only a couple of blips’ (pre- last CR) ‘ WP may have made a mistake, ‘Situation at AHZ is rather complicated’, ‘Shareholder hysteria’ etc, etc.

Yes Admedus is a speculative stock! ‘We’ have not confused it with a ‘blue chip’, I believe at least twice WP has used the word ‘bankable’ in discussion on the future of this company!, WP rhetoric was compelling, probably more so if he hadn’t ‘overspent’ AND failed to deliver.

As a ‘smallish’ holder I would also be inclined to be a little more ‘lenient’ on the past/current decisions of this company, as a more ‘largish’ holder I expect a little more accountability.

As you are not ‘interested’ in me you won’t be reading this post will you’, lol.

In the interim just, perhaps, call it as you see it, dont worry about the ‘intellectual’ exercise of ‘balancing’, give posters a ounce of credit/brains to make up their own minds.

Expand

Yours is a very loaded and inaccurate review not of the stock, but a very strong attempt to discredit me.

I'm NOT on duty for each stock that I hold. Why do you imagine that's needed? I guess only traders have that mentality.

You're free to make demands of the company, but why do you do it on HC rather than contacting them yourself?

You protest WAAAY too muchI

Points for effort though. It shows how much you care. LOL

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ME1

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-430

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-430

Top Stories

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024